| 0 |
SENSORY PROCESSING SENSITIVITY |
1 |
0.0227 |
| 1 |
BULLOUS IMPETIGO |
1 |
0.0167 |
| 2 |
PLATELET AGGREGATION ABNORMAL |
1 |
0.0066 |
| 3 |
ADRENAL SUPPRESSION |
5 |
0.0059 |
| 4 |
GASTROSTOMY TUBE SITE COMPLICATION |
1 |
0.0050 |
| 5 |
OCULAR ROSACEA |
1 |
0.0049 |
| 6 |
GINGIVAL OPERATION |
1 |
0.0045 |
| 7 |
ADENOIDAL DISORDER |
1 |
0.0038 |
| 8 |
SHOPLIFTING |
1 |
0.0036 |
| 9 |
PERIORBITAL IRRITATION |
1 |
0.0029 |
| 10 |
TRIGEMINAL NERVE DISORDER |
1 |
0.0029 |
| 11 |
EAR OPERATION |
1 |
0.0027 |
| 12 |
APPLICATION SITE LACERATION |
1 |
0.0024 |
| 13 |
INSULIN RESISTANCE |
5 |
0.0024 |
| 14 |
FAECAL VOMITING |
1 |
0.0019 |
| 15 |
THEFT |
1 |
0.0015 |
| 16 |
INFLAMMATORY PAIN |
1 |
0.0015 |
| 17 |
GASTROINTESTINAL SURGERY |
1 |
0.0013 |
| 18 |
COMPULSIVE SEXUAL BEHAVIOUR |
1 |
0.0012 |
| 19 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
2 |
0.0010 |
| 20 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 21 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 22 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 23 |
SUDDEN ONSET OF SLEEP |
1 |
0.0007 |
| 24 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 25 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 26 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 27 |
ANALGESIC DRUG LEVEL INCREASED |
1 |
0.0006 |
| 28 |
SKULL FRACTURE |
1 |
0.0006 |
| 29 |
RESPIRATORY ALKALOSIS |
1 |
0.0006 |
| 30 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 31 |
EROSIVE OESOPHAGITIS |
1 |
0.0006 |
| 32 |
FIXED ERUPTION |
1 |
0.0006 |
| 33 |
PUPIL FIXED |
1 |
0.0006 |
| 34 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 35 |
DIFFUSE ALOPECIA |
1 |
0.0005 |
| 36 |
INFECTED SKIN ULCER |
1 |
0.0005 |
| 37 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 38 |
SELF-MEDICATION |
2 |
0.0005 |
| 39 |
COMPULSIVE SHOPPING |
1 |
0.0005 |
| 40 |
IMPULSE-CONTROL DISORDER |
1 |
0.0005 |
| 41 |
HORDEOLUM |
2 |
0.0005 |
| 42 |
SKIN TIGHTNESS |
2 |
0.0004 |
| 43 |
EYELID IRRITATION |
1 |
0.0004 |
| 44 |
RETINAL DISORDER |
1 |
0.0004 |
| 45 |
GAMBLING DISORDER |
1 |
0.0004 |
| 46 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 47 |
IMMUNE-MEDIATED MYOSITIS |
1 |
0.0004 |
| 48 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 49 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 50 |
HAEMATOLOGICAL MALIGNANCY |
1 |
0.0004 |
| 51 |
MULTIPLE-DRUG RESISTANCE |
1 |
0.0003 |
| 52 |
SKIN WEEPING |
1 |
0.0003 |
| 53 |
FACIAL BONES FRACTURE |
1 |
0.0003 |
| 54 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 55 |
SKIN FISSURES |
5 |
0.0003 |
| 56 |
BLEPHARITIS |
1 |
0.0002 |
| 57 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0002 |
| 58 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 59 |
HEPATOTOXICITY |
5 |
0.0002 |
| 60 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 61 |
ROSACEA |
1 |
0.0002 |
| 62 |
EYE INFLAMMATION |
2 |
0.0002 |
| 63 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 64 |
ANAL FISSURE |
1 |
0.0002 |
| 65 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 66 |
PULMONARY ALVEOLAR HAEMORRHAGE |
1 |
0.0002 |
| 67 |
MOUTH SWELLING |
1 |
0.0002 |
| 68 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 69 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 70 |
NASAL DRYNESS |
1 |
0.0002 |
| 71 |
DRUG SPECIFIC ANTIBODY PRESENT |
1 |
0.0002 |
| 72 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 73 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 74 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 75 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 76 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 77 |
ARTHROPOD BITE |
1 |
0.0001 |
| 78 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 79 |
GINGIVAL PAIN |
1 |
0.0001 |
| 80 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 81 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 82 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 83 |
DRY SKIN |
16 |
0.0001 |
| 84 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 85 |
ECZEMA |
6 |
0.0001 |
| 86 |
DERMATITIS ATOPIC |
6 |
0.0001 |
| 87 |
SKIN EXFOLIATION |
9 |
0.0001 |
| 88 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 89 |
TENDERNESS |
1 |
0.0001 |
| 90 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 91 |
SCRATCH |
1 |
0.0001 |
| 92 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 93 |
SKIN INFECTION |
1 |
0.0001 |
| 94 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 95 |
REBOUND EFFECT |
1 |
0.0001 |
| 96 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 97 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 98 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 99 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 100 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 101 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 102 |
EAR INFECTION |
2 |
0.0001 |
| 103 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 104 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 105 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 106 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 107 |
THERAPEUTIC RESPONSE DECREASED |
4 |
0.0001 |
| 108 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 109 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 110 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 111 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 112 |
TENDONITIS |
1 |
0.0001 |
| 113 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 114 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 115 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 116 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 117 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 118 |
CANDIDA INFECTION |
1 |
0.0001 |
| 119 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 120 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 121 |
TOOTHACHE |
1 |
0.0001 |
| 122 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 123 |
THINKING ABNORMAL |
1 |
0.0001 |
| 124 |
PROTEINURIA |
1 |
0.0001 |
| 125 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 126 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 127 |
HERNIA |
1 |
0.0001 |
| 128 |
EAR PAIN |
1 |
0.0001 |
| 129 |
BONE PAIN |
3 |
0.0001 |
| 130 |
DISABILITY |
1 |
0.0001 |
| 131 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 132 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 133 |
PERITONITIS |
1 |
0.0000 |
| 134 |
EATING DISORDER |
1 |
0.0000 |
| 135 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 136 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 137 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 138 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 139 |
RASH PAPULAR |
1 |
0.0000 |
| 140 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 141 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 142 |
DRY EYE |
2 |
0.0000 |
| 143 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 144 |
DIPLOPIA |
1 |
0.0000 |
| 145 |
JOINT STIFFNESS |
1 |
0.0000 |
| 146 |
ANHEDONIA |
1 |
0.0000 |
| 147 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 148 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 149 |
SKIN LESION |
1 |
0.0000 |
| 150 |
WOUND |
1 |
0.0000 |
| 151 |
EYE PAIN |
2 |
0.0000 |
| 152 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 153 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 154 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 155 |
NASAL CONGESTION |
2 |
0.0000 |
| 156 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 157 |
FEELING HOT |
2 |
0.0000 |
| 158 |
INJECTION SITE RASH |
1 |
0.0000 |
| 159 |
SWELLING |
3 |
0.0000 |
| 160 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 161 |
HEAD INJURY |
1 |
0.0000 |
| 162 |
PRURITUS |
12 |
0.0000 |
| 163 |
NIGHT SWEATS |
1 |
0.0000 |
| 164 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 165 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 166 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 167 |
FUNGAL INFECTION |
1 |
0.0000 |
| 168 |
EYE PRURITUS |
1 |
0.0000 |
| 169 |
RASH MACULAR |
1 |
0.0000 |
| 170 |
INJURY |
2 |
0.0000 |
| 171 |
HYPOXIA |
1 |
0.0000 |
| 172 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 173 |
RASH |
12 |
0.0000 |
| 174 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 175 |
EYE SWELLING |
1 |
0.0000 |
| 176 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 177 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 178 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 179 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 180 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 181 |
HYPOACUSIS |
1 |
0.0000 |
| 182 |
CONDITION AGGRAVATED |
7 |
0.0000 |
| 183 |
SEPTIC SHOCK |
1 |
0.0000 |
| 184 |
INJECTION SITE PAIN |
7 |
0.0000 |
| 185 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 186 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 187 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 188 |
VISION BLURRED |
3 |
0.0000 |
| 189 |
SKIN IRRITATION |
1 |
0.0000 |
| 190 |
TINNITUS |
1 |
0.0000 |
| 191 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 192 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 193 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 194 |
COMA |
1 |
0.0000 |
| 195 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 196 |
CONTUSION |
2 |
0.0000 |
| 197 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 198 |
ILLNESS |
2 |
0.0000 |
| 199 |
INFLAMMATION |
1 |
0.0000 |
| 200 |
PANCREATITIS |
1 |
0.0000 |
| 201 |
DEPRESSED MOOD |
1 |
0.0000 |
| 202 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 203 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 204 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 205 |
INFLUENZA |
2 |
0.0000 |
| 206 |
BLISTER |
1 |
0.0000 |
| 207 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 208 |
FLATULENCE |
1 |
0.0000 |
| 209 |
LETHARGY |
1 |
0.0000 |
| 210 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 211 |
VERTIGO |
1 |
0.0000 |
| 212 |
RHINORRHOEA |
1 |
0.0000 |
| 213 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 214 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 215 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 216 |
OFF LABEL USE |
13 |
0.0000 |
| 217 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 218 |
BURNING SENSATION |
1 |
0.0000 |
| 219 |
SLEEP DISORDER |
1 |
0.0000 |
| 220 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 221 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 222 |
CONSTIPATION |
3 |
0.0000 |
| 223 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 224 |
EPISTAXIS |
1 |
0.0000 |
| 225 |
ACNE |
1 |
0.0000 |
| 226 |
DIABETES MELLITUS |
1 |
0.0000 |
| 227 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 228 |
DRY MOUTH |
1 |
0.0000 |
| 229 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 230 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 231 |
BALANCE DISORDER |
1 |
0.0000 |
| 232 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 233 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 234 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 235 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 236 |
CARDIAC DISORDER |
1 |
0.0000 |
| 237 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 238 |
DYSPHAGIA |
1 |
0.0000 |
| 239 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 240 |
ALOPECIA |
2 |
0.0000 |
| 241 |
HEART RATE INCREASED |
1 |
0.0000 |
| 242 |
SYNCOPE |
1 |
0.0000 |
| 243 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 244 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 245 |
SINUSITIS |
1 |
0.0000 |
| 246 |
ARTHRALGIA |
4 |
0.0000 |
| 247 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 248 |
HYPERTENSION |
2 |
0.0000 |
| 249 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 250 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 251 |
DECREASED APPETITE |
2 |
0.0000 |
| 252 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 253 |
DRUG INEFFECTIVE |
11 |
0.0000 |
| 254 |
JOINT SWELLING |
1 |
0.0000 |
| 255 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 256 |
PAIN |
5 |
0.0000 |
| 257 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 258 |
PSORIASIS |
1 |
0.0000 |
| 259 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 260 |
WEIGHT DECREASED |
2 |
0.0000 |
| 261 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 262 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 263 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 264 |
HEADACHE |
4 |
0.0000 |
| 265 |
PARAESTHESIA |
1 |
0.0000 |
| 266 |
DIARRHOEA |
4 |
0.0000 |
| 267 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 268 |
URTICARIA |
1 |
0.0000 |
| 269 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 270 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 271 |
PYREXIA |
2 |
0.0000 |
| 272 |
COVID-19 |
1 |
0.0000 |
| 273 |
MUSCLE SPASMS |
1 |
0.0000 |
| 274 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 275 |
ASTHENIA |
2 |
0.0000 |
| 276 |
ERYTHEMA |
1 |
0.0000 |
| 277 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 278 |
DEPRESSION |
1 |
0.0000 |
| 279 |
BACK PAIN |
1 |
0.0000 |
| 280 |
VOMITING |
2 |
0.0000 |
| 281 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 282 |
DIZZINESS |
2 |
0.0000 |
| 283 |
NAUSEA |
3 |
0.0000 |
| 284 |
INSOMNIA |
1 |
0.0000 |
| 285 |
COUGH |
1 |
0.0000 |
| 286 |
ANXIETY |
1 |
0.0000 |
| 287 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 288 |
FATIGUE |
1 |
0.0000 |